| The Changing Tide: Current Advancements in Clinical Trial Disclosure | | Date(s): | October 14 - 16, 2008 |  | | Topic: | Clinical Trial Registries and Results Databases | | Location: | Chicago, IL | | Presenter: | John McKenney, President, SEC Associates, Inc. | | This 2.5-day event will start with a half-day workshop designed for those new to the field of clinical trial disclosure. That will be followed by a two-day workshop focused on more advanced topics and current events driving public transparency of clinical trials. SEC's John McKenney will present a session entitled "Plotting the Course in the Maze of International Clinical Trial Disclosure Requirements and Their Related Registry Websites". | Click here for more information.
| Click here to download file information.
|  |
| BIO Member Working Meeting | | Date(s): | October 23, 2008 |  | | Topic: | International Clinical Trial Disclosure | | Location: | via Webex | | Presenter: | John McKenney, President, SEC Associates, Inc. | | SEC President John McKenney will present to a Biotechnology Industry Organization (BIO) members-only working meeting on current events and issues regarding Clinical Trial Disclosure in the international community. | |
| The Clinical Trial Disclosure Seminar: Navigating the Expanded Clinical Trial Registry and Results Data Disclosure Requirements for Drugs, Biologics and Medical Devices | | Date(s): | November 18, 2008 |  | | Topic: | Clinical Trial Disclosure Requirements in the International Community | | Location: | San Francisco, CA | | Presenter: | John McKenney, President, SEC Associates, Inc. | | This one-day event is the first Clinical Trial Disclosure conference to be held on the West Coast. SEC's John McKenney will present a session on public Clinical Trial Registration and Results Disclosure requirements in various locations around the world. | Click here for more information.
| Click here to download file information.
| |
| ExL Pharma's 4th Annual Clinical Data Disclosure Summit | | Date(s): | January 12 - 13, 2009 |  | | Topic: | Implementing & Maintaining Compliant Trial Registries & Results Databases for Drugs, Biologics & Medical Devices | | Location: | Washington, D.C. | | Presenter: | Leaders from U.S. and International Government, Industry, and Professional Institutions | | SEC Associates will be exhibiting TransparentCT™ - The International Clinical Trial Disclosure Knowledge Base at ExL Pharma's 4th Annual Clinical Data Disclosure Summit in Washington, D.C. on January 12-13, 2009. A downloadable brochure and more information will be available here soon. | Click here for more information.
| |
| CBI’s European Forum on Clinical Trial Registries and Results Databases | | Date(s): | February 3 - 4, 2009 |  | | Topic: | Identify and Tackle Challenges in International Disclosure Requirements | | Location: | London, UK | | Presenter: | John McKenney, SEC president, and Bob Paarlberg, Director, Global Regulatory Policy and Intelligence, UCB, Inc. | | Ever-expanding global regulations and standards for clinical trial registration and results disclosure require continuous monitoring and process changes for companies that conduct clinical trials outside the U.S. Global harmonization of transparency requirements is no closer now than it was in 2005. If anything, nationalistic demands for unique clinical trial websites/databases are increasing. This session examines various international public disclosure requirements, explains similarities and differences, and offers ideas on how to approach the challenges of compliance with global clinical trial transparency requirements as well as challenges to ensure consistency of clinical trial information being provided in the public domain. A downloadable brochure will be available here soon. | Click here for more information.
| |
| CBI’s 4th Forum on Clinical Trial Registries and Results Databases | | Date(s): | April 29 - 30, 2009 | | | Topic: | Identify and Tackle Challenges in International Disclosure Requirements | | Location: | Washington, D.C., area | | Presenter: | John McKenney, SEC president, and Bob Paarlberg, Director, Global Regulatory Policy and Intelligence, UCB, Inc. | | Ever-expanding global regulations and standards for clinical trial registration and results disclosure require continuous monitoring and process changes for companies that conduct clinical trials outside the U.S. Global harmonization of transparency requirements is no closer now than it was in 2005. If anything, nationalistic demands for unique clinical trial websites/databases are increasing. This session examines various international public disclosure requirements, explains similarities and differences, and offers ideas on how to approach the challenges of compliance with global clinical trial transparency requirements as well as challenges to ensure consistency of clinical trial information being provided in the public domain. A downloadable brochure will be available here soon. | Click here for more information.
| |
|
